FDA goes easy on mobile apps?; CRO bets on pharma's thirst for analytics

> FDA affirms that only a fraction of medical apps would likely face regulatory review, a fresh sign that the agency is unlikely to stifle progress in mobile medicine. Item

> Bioanalytical CRO MedeoLinx has landed business from the 10 top drugmakers, which have sought analytics services to slice and dice genomics and clinical trials data. Report

> Better than Google ($GOOG)? Well, at least when it comes to online searches for rare diseases info, a team from the Technical University of Denmark believes that its FindZebra software trumps the web giant. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.